Bitcoin Price Watch: Key Resistance at $95.5K Holds the Next Bullish Trigger
Bitcoin is consolidating just beneath its recent peak, following a sharp rally that pushed it to the upper bounds of
Read more
Resistance
Ethereum Grips $1,800 Resistance — $2,000 Remains in Sight
Key Takeaways: Ethereum surged over 15% recently, approaching the $1,800 resistance zone. Investor sentiment remains pressured by institutional selling and
Read more
Is XRP About to Shatter Resistance? Technicals Hint at Lift-Off
With a price of $2.155 to $2.163 over the last hour, a market cap of $124 billion, and a global
Read more
Bitcoin Price Watch: Key Support and Resistance Levels to Watch Now
On Saturday, bitcoin traded at $86,189 on March 8, 2025, with a market capitalization of $1.70 trillion and a 24-hour
Read more
BTC Price Analysis: Bulls Eye $95K as Key Resistance Levels Tighten
Bitcoin vaulted to $90,106, reflecting a $1.78 trillion market valuation and $52 billion in daily trading activity, as price volatility
Read more
VINE Coin Hits New Highs: Can It Reach $3.50 or Will Resistance Hold? | by Samuel O. Adediran | The Capital | Jan, 2025
The recent price of VINE coin has been initiating higher lows, sustaining an uptrend on the 4H chart. The ascending
Read more
Bitcoin Technical Analysis: Key Resistance at $109K Holds the Fate of the Next Big Move
Bitcoin, currently valued at $107,075 to $107,748 over the last hour, has a market capitalization of $2.12 trillion and a
Read more
Full Support or Quiet Resistance: Ukraine War Splits Russia’s Buddhists
On a November day in Russia’s Far East, residents of a suburb of Buryatia’s capital Ulan-Ude gathered alongside local officials to
Read moreOptimizing Python Trading: Leveraging RSI with Support & Resistance for High-Accuracy Signals | by Aydar Murt | The Capital | Jan, 2025
Once support/resistance trends are validated, the next step is to incorporate RSI to fine-tune trading signals. A unified approach helps
Read more
40 million could die from antibiotic resistance – ex-health chief in UK — RT World News
Developing new antimicrobial drugs is financially unappealing for pharmaceutical corporations, Sally Davies has said Antimicrobial resistance could claim 40 million
Read more